#brh #odx #avct #tils #sng #hemo #ncyt #tek #gdr #stockwatch #stocks
BRH Aptamer scientists continue working to develop aptamer binder selective for the spike protein in SARS CoV-2 expect to complete 3-4 weeks.point-of-use test for detection and proof-of-concept in two months.